Teladoc officer to sell 17,805 shares under Rule 144

A Teladoc Health insider filed a Rule 144 notice to sell vested restricted shares, including amounts to cover related tax obligations.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer for which Charles Divita III filed a notice of proposed sale of common stock under Rule 144. The notice covers a planned sale of 17,805 shares of Teladoc common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $108,683.50.

The shares relate to restricted stock vesting on September 10, 2026, and the filer notes that the sale includes an amount necessary to cover a tax obligation arising from the settlement of a vested equity award distribution. In the prior three months, Charles Divita reported additional Teladoc common stock sales totaling 36,401 shares for aggregate proceeds of $240,944.59.

Key Figures

Shares to be sold under Rule 144: 17,805 shares Aggregate market value of proposed sale: $108,683.50 Shares sold on June 11, 2026: 18,074 shares +5 more

8 metrics

Shares to be sold under Rule 144 17,805 shares Proposed Teladoc Health common stock sale covered by the Form 144 notice

Aggregate market value of proposed sale $108,683.50 Estimated value of 17,805 Teladoc Health shares listed in the Form 144

Shares sold on June 11, 2026 18,074 shares Teladoc Health common stock sales in the three months prior to the notice

Proceeds from June 11, 2026 sale $125,460.67 Aggregate proceeds from Teladoc Health shares sold on June 11, 2026

Shares sold on September 2, 2026 18,327 shares Teladoc Health common stock sales in the three months prior to the notice

Proceeds from September 2, 2026 sale $115,483.92 Aggregate proceeds from Teladoc Health shares sold on September 2, 2026

Total shares sold in past 3 months 36,401 shares Sum of Teladoc Health shares sold on June 11 and September 2, 2026

Total proceeds from past 3 months sales $240,944.59 Combined proceeds from June 11 and September 2, 2026 Teladoc share sales

Key Terms

Rule 144, restricted stock vesting, vested equity award distribution, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/10/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Charles Divita"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Teladoc Health (TDOC)?

The filing discloses that Charles Divita III plans to sell 17,805 shares of Teladoc Health common stock under Rule 144, with an indicated aggregate market value of $108,683.50, in connection with restricted stock that vested on September 10, 2026.

Who is selling Teladoc (TDOC) shares and through which broker?

Charles Divita III is the person for whose account Teladoc Health common stock is to be sold. The intermediary listed is Fidelity Brokerage Services LLC, identified as the broker handling the proposed Rule 144 sale of 17,805 shares.

How many Teladoc (TDOC) shares are covered by this new Rule 144 notice?

The notice covers a proposed sale of 17,805 shares of Teladoc Health common stock. The filing also lists an associated aggregate market value of $108,683.50 for this block of shares as of the information provided.

What is the purpose of the Teladoc (TDOC) share sale mentioned in the remarks?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating that part of the proposed transaction is tied to tax withholding on equity compensation.

What Teladoc (TDOC) stock sales by Charles Divita occurred in the past 3 months?

The filing reports two prior Teladoc common stock sales: 18,074 shares on June 11, 2026 for $125,460.67, and 18,327 shares on September 2, 2026 for $115,483.92, totaling 36,401 shares and $240,944.59 over the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 03:14 PM EDT Accepted by SEC EDGAR 09/11/2026 - 03:14 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347535
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	DIVITA CHARLES III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17805	108683.50	181684021	09/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2026	Restricted Stock Vesting	Issuer			17805	09/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Divita 155 E 44th Street Suite 1700 New York NY 10017	Common	06/11/2026	18074	125460.67
Charles Divita 155 E 44th Street Suite 1700 New York NY 10017	Common	09/02/2026	18327	115483.92

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Charles Divita
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)